Lipocine Inc
NASDAQ:LPCN
Balance Sheet
Balance Sheet Decomposition
Lipocine Inc
Lipocine Inc
Balance Sheet
Lipocine Inc
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
45
|
28
|
20
|
6
|
3
|
8
|
10
|
19
|
3
|
3
|
5
|
6
|
|
| Cash Equivalents |
0
|
0
|
45
|
28
|
20
|
6
|
3
|
8
|
10
|
19
|
3
|
3
|
5
|
6
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
24
|
21
|
18
|
7
|
4
|
0
|
42
|
29
|
17
|
15
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
2
|
2
|
1
|
1
|
|
| Total Current Assets |
0
|
0
|
46
|
28
|
45
|
27
|
25
|
21
|
20
|
25
|
46
|
34
|
23
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
46
N/A
|
28
-39%
|
45
+62%
|
27
-40%
|
25
-7%
|
21
-18%
|
20
-6%
|
25
+29%
|
52
+107%
|
38
-28%
|
23
-39%
|
23
-2%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
3
|
1
|
2
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
2
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
2
|
3
|
1
|
6
|
4
|
5
|
7
|
6
|
2
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
4
|
2
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
1
+12 700%
|
2
+27%
|
3
+108%
|
1
-61%
|
6
+377%
|
11
+80%
|
13
+17%
|
10
-25%
|
7
-31%
|
2
-72%
|
3
+38%
|
2
-43%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
48
|
68
|
86
|
105
|
126
|
138
|
151
|
172
|
173
|
183
|
200
|
200
|
|
| Additional Paid In Capital |
0
|
0
|
93
|
95
|
129
|
131
|
145
|
148
|
157
|
187
|
218
|
219
|
220
|
221
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
45
N/A
|
26
-41%
|
42
+59%
|
26
-38%
|
19
-27%
|
9
-50%
|
6
-33%
|
15
+144%
|
46
+197%
|
36
-22%
|
20
-43%
|
21
+3%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
46
N/A
|
28
-39%
|
45
+62%
|
27
-40%
|
25
-7%
|
21
-18%
|
20
-6%
|
25
+29%
|
52
+107%
|
38
-28%
|
23
-39%
|
23
-2%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
5
|
5
|
5
|
5
|
|